Nativis Inc., a clinical stage life science bio-electronics company developing non-invasive, safe and highly effective treatments for cancers and other serious diseases, today announced that it will be featured as a presenting company at the 18th Annual Rodman & Renshaw Global Investment Conference. The meeting will be held September 11-13, 2016, at The Lotte New York Palace Hotel in New York City.
The Conference facilitates one-on-one investor meetings and engaged Q&A sessions with investors and companies from around the globe. Chris Rivera, Nativis President and Chief Executive Officer, will provide an overview and update of the Company’s strategy during a live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
Institutional investors who would like to attend the Company’s presentation can register to attend at www.rodmanevents.com. Once registration is confirmed, investors can request a one-on-one meeting with Chris Rivera. Nativis’ presentation details are as follows:
Date: Monday, September 12, 2016
Time: 5:05PM ET
Room: Adams, Floor 4
About Nativis, Inc.
Founded in 2002, Nativis Inc. is a clinical-stage bio-electronics company pioneering a novel platform technology to treat cancer and other serious diseases. The company is located in Seattle’s South Lake Union biotech neighborhood. Nativis’ mission is to improve the human and animal condition by providing non-invasive, safe and highly effective treatments for cancers and other serious diseases.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160830005400/en/Business Wire
Last updated on: 30/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.